SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $360,000 | -6.0% | 371,000 | -5.1% | 0.03% | +4.0% |
| Q1 2022 | $383,000 | +1.9% | 391,000 | +2.6% | 0.02% | +4.2% |
| Q4 2021 | $376,000 | -6.9% | 381,000 | -7.3% | 0.02% | -17.2% |
| Q3 2021 | $404,000 | -6.9% | 411,000 | -6.8% | 0.03% | -9.4% |
| Q2 2021 | $434,000 | +2.1% | 441,000 | 0.0% | 0.03% | -5.9% |
| Q1 2021 | $425,000 | -10.5% | 441,000 | -12.0% | 0.03% | -19.0% |
| Q4 2020 | $475,000 | +3.0% | 501,000 | 0.0% | 0.04% | -12.5% |
| Q3 2020 | $461,000 | -3.2% | 501,000 | -7.4% | 0.05% | -9.4% |
| Q2 2020 | $476,000 | +0.2% | 541,000 | -8.5% | 0.05% | -18.5% |
| Q1 2020 | $475,000 | -25.2% | 591,000 | -15.7% | 0.06% | -14.5% |
| Q4 2019 | $635,000 | -9.3% | 701,000 | -7.3% | 0.08% | -19.1% |
| Q3 2019 | $700,000 | -10.5% | 756,000 | -5.6% | 0.09% | -16.8% |
| Q2 2019 | $782,000 | – | 801,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $45,147,000 | 3.42% |
| Ayrton Capital LLC | 2,000,000 | $1,982,000 | 1.87% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $68,018,000 | 1.78% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 74,027,000 | $73,675,000 | 1.54% |
| DeepCurrents Investment Group LLC | 33,182,000 | $32,736,000 | 1.02% |
| Penn Mutual Asset Management | 675 | $665,000 | 0.71% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,897,000 | $7,533,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,901,000 | $19,714,000 | 0.22% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,940,000 | $9,858,000 | 0.09% |
| Jefferies Group LLC | 12,740,000 | $12,658,285 | 0.07% |